Centre Hospitalier Universitaire de Rennes
Rennes, 35000, France
NCT Number: NCT04579289
REMPAR EHPAD study addresses environmental and managerial factors associated with an outbreak of COVID 19 in French Long Term Care Institutions in the spring of 2020. The survey used a mixed methodology, combining qualitative and quantitative approaches, with a questionnaire send to all identified institutions (n=501) and qualitative interviews with facility directors (n=21).
Looking for future studies?
Notify MeAll sexes
Observational
Rennes, 35000, France
A questionnaire was e-mailed to all identified institutions, with 3 reminders in one month. It included 39 questions concerning :
The investigators conducted semi-directed face-to-face interviews with facility directors. The investigators realized a purposive sample to assure maximal variability of the facilities (location, size, status, severity of the outbreak). The interview guide focused on structural, organizational, and human factors at stake in outbreak management, to identify incentives and obstacles associated with an easier crisis management.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
A questionnaire was e-mailed to all identified institutions, with 3 reminders in one month. It included 39 questions concerning :
Time frame: 01 september 2020, survey closing date
Number of case (confirmed or probable) of COVID 19 in each facility
Rennes University Hospital
Other
Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions_COVID-19
Acronym: REMPAR-EHPAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04924881
COVID-19, Coronaviridae Infections
Shatin, Hong Kong
View Trial DetailsNCT04939506
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial DetailsNCT04705116
COVID-19, Coronaviridae Infections
Los Angeles, California, United States
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial Details